Schistosoma mansoni proteins attenuate gastrointestinal motility disturbances during experimental colitis in mice

World J Gastroenterol. 2010 Feb 14;16(6):703-12. doi: 10.3748/wjg.v16.i6.703.


Aim: To investigate the therapeutic effect of Schistosoma mansoni (S. mansoni) soluble worm proteins on gastrointestinal motility disturbances during experimental colitis in mice.

Methods: Colitis was induced by intrarectal injection of trinitrobenzene sulphate (TNBS) and 6 h later, mice were treated ip with S. mansoni proteins. Experiments were performed 5 d after TNBS injection. Inflammation was quantified using validated inflammation parameters. Gastric emptying and geometric center were measured to assess in vivo gastrointestinal motility. Peristaltic activity of distal colonic segments was studied in vitro using a modified Trendelenburg set-up. Cytokine profiles of T-lymphocytes isolated from the colon were determined by real time reverse transcriptase-polymerase chain reaction.

Results: Intracolonic injection of TNBS caused severe colitis. Treatment with S. mansoni proteins significantly ameliorated colonic inflammation after 5 d. TNBS did not affect gastric emptying but significantly decreased the geometric center and impaired colonic peristaltic activity 5 d after the induction of colitis. Treatment with S. mansoni proteins ameliorated these in vivo and in vitro motility disturbances. In addition, TNBS injection caused a downregulation of effector T cell cytokines after 5 d, whereas a S. mansoni protein effect was no longer observed at this time point.

Conclusion: Treatment with S. mansoni proteins attenuated intestinal inflammation and ameliorated motility disturbances during murine experimental colitis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Colitis / chemically induced
  • Colitis / drug therapy*
  • Colitis / physiopathology
  • Cytokines / metabolism
  • Disease Models, Animal
  • Gastrointestinal Motility / drug effects
  • Gastrointestinal Motility / physiology*
  • Helminth Proteins / metabolism
  • Helminth Proteins / pharmacology
  • Helminth Proteins / therapeutic use*
  • Male
  • Mice
  • Peristalsis / drug effects
  • Peristalsis / physiology
  • Schistosoma mansoni / metabolism*
  • T-Lymphocyte Subsets / metabolism
  • T-Lymphocyte Subsets / pathology
  • Trinitrobenzenesulfonic Acid / adverse effects


  • Cytokines
  • Helminth Proteins
  • Trinitrobenzenesulfonic Acid